Informations générales (source: ClinicalTrials.gov)
Diagnostic Accuracy of Optimized Diffusion-Weighted Imaging for Detecting Anterior Ischemic Optic Neuropathy (DACODAC)
Observational
Fondation Ophtalmologique Adolphe de Rothschild (Voir sur ClinicalTrials)
octobre 2022
mars 2028
29 juin 2024
The patient presents to the ophthalmological emergencies and / or to the internal
medicine department. NOIA clinical discovery Patient referred in radiology for brain and
visual MRI. The two sequences added by the research (8 minutes) will be added to that of
the treatment.
Etablissements
Les établissements d'Île-de-France ayant mis à jour leurs données Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
HOPITAL FONDATION A. DE ROTHSCHILD | Guillaume POILLON | 21/06/2024 13:33:23 | Contacter | ||
Les établissements sans correspondance certaine dans le répertoire FINESS dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
CHU de LILLE - 59000 - Lille - France | Olivier OUTTERYCK | Contact (sur clinicalTrials) | |||
Chu Rouen - 76100 - Rouen - France | Emmanuel GERARDIN | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion Criteria:
- Patient over 18 years old
- Patient with suspected NOIA, evoked after clinical examination by a specialized
ophthalmologist
- For which a brain and visual MRI is planned
- Express consent to participate in the study
- Affiliate or beneficiary of a Social Security scheme
- Patient over 18 years old
- Patient with suspected NOIA, evoked after clinical examination by a specialized
ophthalmologist
- For which a brain and visual MRI is planned
- Express consent to participate in the study
- Affiliate or beneficiary of a Social Security scheme
- Contraindication to MRI (electrical device, metallic foreign body, claustrophobia)
- Patient benefiting from a legal protection measure
- Pregnant or breastfeeding woman